Jena Schmitz, APRN

Jena Schmitz practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Jena Schmitz's NPI, 1730647132, was assigned on March 5, 2019. Jena Schmitz holds Florida license 11001470.

Jena Schmitz's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Jena Schmitz's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Jena Schmitz to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jena Schmitz practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Jena Schmitz's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Jena Schmitz is licensed in Florida.

CMS data shows 451 Medicare services from Jena Schmitz across 4 procedure codes in 2024, for 124 Medicare patients. Medicare paid $27,742 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Jena Schmitz in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 4.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jena Schmitz's median patient age at 68, with 45% women.

In 2024, Jena Schmitz wrote 608 Medicare Part D claims for 115 patients. 88% of them were for generic drugs. CMS names the drug for 344 of them, across 14 drugs with 11 or more claims each, at $816,416 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Jena Schmitz for performance year 2024, reported as part of a group. Jena Schmitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jena Schmitz as offering telehealth.

CMS Open Payments shows 12 general payments to Jena Schmitz from 3 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 73% of the total. Incyte Corporation paid the most, $3,867.